Literature DB >> 16582936

Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKCvarepsilon pathway.

Delphine Mousseaux1, Lionel Le Gallic, Joanne Ryan, Catherine Oiry, Didier Gagne, Jean-Alain Fehrentz, Jean-Claude Galleyrand, Jean Martinez.   

Abstract

1. The growth hormone secretagogue receptor 1a (GHSR-1a) is a G-protein coupled receptor, involved in the biological actions of ghrelin by triggering inositol phosphates and calcium intracellular second messengers. It has also been reported that ghrelin could activate the 44- and 42-kDa extracellular signal-regulated protein kinases (ERK1/2) in different cell lines, but it is not clear whether this regulation is GHSR-1a dependent or not. 2. To provide direct evidence for the coupling of GHSR-1a to ERK1/2 activation, this pathway has been studied in a heterologous expression system. 3. Thus, in Chinese hamster ovary (CHO) cells we showed that ghrelin induced, via the human GHSR-1a, a transient and dose-dependent activation of ERK1/2 leading to activation of the transcriptional factor Elk1. 4. We then investigated the precise mechanisms involved in GHSR-1a-mediated ERK1/2 activation using various specific inhibitors and dominant-negative mutants and found that internalization of GHSR-1a was not necessary. Our results also indicate that phospholipase C (PLC) was involved in GHSR-1a-mediated ERK1/2 activation, however, pathways like tyrosine kinases, including Src, and phosphoinositide 3-kinases were not found to be involved. GHSR-1a-mediated ERK1/2 activation was abolished both by a general protein kinase C (PKC) inhibitor, Gö6983, and by PKC depletion using overnight pretreatment with phorbol ester. Moreover, the calcium chelator, BAPTA-AM, and the inhibitor of conventional PKCs, Gö6976, had no effect on the GHSR-1a-mediated ERK1/2 activation, suggesting the involvement of novel PKC isoforms (epsilon, delta), but not conventional or atypical PKCs. Further analyses suggest that PKCepsilon is required for the activation of ERK1/2. 5. Taken together, these data suggest that ghrelin, through GHSR-1a, activates the Elk1 transcriptional factor and ERK1/2 by a PLC- and PKCepsilon-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16582936      PMCID: PMC1751558          DOI: 10.1038/sj.bjp.0706727

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  81 in total

1.  Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors.

Authors:  K L Pierce; S Maudsley; Y Daaka; L M Luttrell; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 2.  Growth hormone secretagogue actions on the pituitary gland: multiple receptors for multiple ligands?

Authors:  C Chen
Journal:  Clin Exp Pharmacol Physiol       Date:  2000 May-Jun       Impact factor: 2.557

3.  Adenosine: A partial agonist of the growth hormone secretagogue receptor.

Authors:  R G Smith; P R Griffin; Y Xu; A G Smith; K Liu; J Calacay; S D Feighner; C Pong; D Leong; A Pomés; K Cheng; L H Van der Ploeg; A D Howard; J Schaeffer; R J Leonard
Journal:  Biochem Biophys Res Commun       Date:  2000-10-05       Impact factor: 3.575

4.  Ghrelin induces adiposity in rodents.

Authors:  M Tschöp; D L Smiley; M L Heiman
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

5.  A role for ghrelin in the central regulation of feeding.

Authors:  M Nakazato; N Murakami; Y Date; M Kojima; H Matsuo; K Kangawa; S Matsukura
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

6.  Involvement of the platelet-derived growth factor receptor in angiotensin II-induced activation of extracellular regulated kinases 1 and 2 in human mesangial cells.

Authors:  U F Mondorf; H Geiger; M Herrero; S Zeuzem; A Piiper
Journal:  FEBS Lett       Date:  2000-04-21       Impact factor: 4.124

7.  Adenosine is an agonist of the growth hormone secretagogue receptor.

Authors:  S Tullin; B S Hansen; M Ankersen; J Møller; K A Von Cappelen; L Thim
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

8.  The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion.

Authors:  A M Wren; C J Small; H L Ward; K G Murphy; C L Dakin; S Taheri; A R Kennedy; G H Roberts; D G Morgan; M A Ghatei; S R Bloom
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

9.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

10.  Phospholipase A(2) and its products are involved in the purinergic receptor-mediated translocation of protein kinase C in CHO-K1 cells.

Authors:  Y Shirai; K Kashiwagi; N Sakai; N Saito
Journal:  J Cell Sci       Date:  2000-04       Impact factor: 5.285

View more
  16 in total

1.  Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling.

Authors:  Céline M'Kadmi; Jean-Philippe Leyris; Lauriane Onfroy; Céline Galés; Aude Saulière; Didier Gagne; Marjorie Damian; Sophie Mary; Mathieu Maingot; Séverine Denoyelle; Pascal Verdié; Jean-Alain Fehrentz; Jean Martinez; Jean-Louis Banères; Jacky Marie
Journal:  J Biol Chem       Date:  2015-09-11       Impact factor: 5.157

2.  KATP channels in the nodose ganglia mediate the orexigenic actions of ghrelin.

Authors:  Gintautas Grabauskas; Xiaoyin Wu; Yuanxu Lu; Andrea Heldsinger; Il Song; Shi-Yi Zhou; Chung Owyang
Journal:  J Physiol       Date:  2015-09-01       Impact factor: 5.182

3.  Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels.

Authors:  Limin Shi; Xiling Bian; Zhiqiang Qu; Zegang Ma; Yu Zhou; KeWei Wang; Hong Jiang; Junxia Xie
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

4.  Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor.

Authors:  Sheng Y Ang; Dana S Hutchinson; Nitin Patil; Bronwyn A Evans; Ross A D Bathgate; Michelle L Halls; Mohammed A Hossain; Roger J Summers; Martina Kocan
Journal:  Br J Pharmacol       Date:  2016-07-13       Impact factor: 8.739

5.  G Protein and β-arrestin signaling bias at the ghrelin receptor.

Authors:  Tama Evron; Sean M Peterson; Nikhil M Urs; Yushi Bai; Lauren K Rochelle; Marc G Caron; Larry S Barak
Journal:  J Biol Chem       Date:  2014-09-26       Impact factor: 5.157

6.  The novel nonapeptide acein targets angiotensin converting enzyme in the brain and induces dopamine release.

Authors:  Jérémie Neasta; Charlène Valmalle; Anne-Claire Coyne; Eric Carnazzi; Gilles Subra; Jean-Claude Galleyrand; Didier Gagne; Céline M'Kadmi; Nicole Bernad; Gilbert Bergé; Sonia Cantel; Philippe Marin; Jacky Marie; Jean-Louis Banères; Marie-Lou Kemel; Valérie Daugé; Karine Puget; Jean Martinez
Journal:  Br J Pharmacol       Date:  2016-03-08       Impact factor: 8.739

7.  Ghrelin directly stimulates glucagon secretion from pancreatic alpha-cells.

Authors:  Jen-Chieh Chuang; Ichiro Sakata; Daisuke Kohno; Mario Perello; Sherri Osborne-Lawrence; Joyce J Repa; Jeffrey M Zigman
Journal:  Mol Endocrinol       Date:  2011-06-30

8.  Ghrelin augments murine T-cell proliferation by activation of the phosphatidylinositol-3-kinase, extracellular signal-regulated kinase and protein kinase C signaling pathways.

Authors:  Jun Ho Lee; Kalpesh Patel; Hyun Jin Tae; Ana Lustig; Jie Wan Kim; Mark P Mattson; Dennis D Taub
Journal:  FEBS Lett       Date:  2014-11-18       Impact factor: 4.124

9.  Ghrelin stimulation of growth hormone-releasing hormone neurons is direct in the arcuate nucleus.

Authors:  Guillaume Osterstock; Pauline Escobar; Violeta Mitutsova; Laurie-Anne Gouty-Colomer; Pierre Fontanaud; François Molino; Jean-Alain Fehrentz; Danielle Carmignac; Jean Martinez; Nathalie C Guerineau; Iain C A F Robinson; Patrice Mollard; Pierre-François Méry
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

Review 10.  Functionally biased signalling properties of 7TM receptors - opportunities for drug development for the ghrelin receptor.

Authors:  B Sivertsen; N Holliday; A N Madsen; B Holst
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.